Presenter: Kevin Spelman, PhD

Original Date: July 30, 2017

While much of the medical community is learning about the cannabinoids, the Cannabis industry itself has been enamored by the terpenes, specifically the mono and sesquiterpenes, with good reason. Many of the terpenes are known to be psychotropic, alter pharmacokinetics and potentially enhance the pharmacodynamic of the cannabinoids. The current understanding of chemovars, is arguably about terpene profiles rather than cannabinoid profiles, and these profiles offer a better understanding of indica vs. sativa differences than supposed speciation.

1.5 Pharmacology CEUs approved by OBNM